ELP3/KAT9 Antikörper
Kurzübersicht für ELP3/KAT9 Antikörper (ABIN7468299)
Target
Alle ELP3/KAT9 (ELP3) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Kreuzreaktivität
- Human
-
Aufreinigung
- Affinity purified by Protein G.
-
Immunogen
- Recombinant protein encompassing a sequence within the center region of human ELP3. The exact sequence is proprietary.
-
Isotyp
- IgG1
-
-
-
-
Applikationshinweise
- WB: 1:500-1:3000. ICC/IF: 1:100-1:1000. IP: 1:100-1:500. Optimal dilutions/concentrations should be determined by the researcher. Not tested in other applications.
-
Kommentare
-
Positive Control: HeLa nuclear extract , 293T , A431 , HeLa , HepG2 Validation: Orthogonal
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 2.35 mg/mL
-
Buffer
- PBS, No Preservative
-
Konservierungsmittel
- Without preservative
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Store as concentrated solution. Centrifuge briefly prior to opening vial. For short-term storage (1-2 weeks), store at 4°C. For long-term storage, aliquot and store at -20°C or below. Avoid multiple freeze-thaw cycles.
-
-
- ELP3/KAT9 (ELP3) (Elongator complex protein 3 (ELP3))
-
Andere Bezeichnung
- elongator acetyltransferase complex subunit 3
-
Hintergrund
-
Synonyms: elongator acetyltransferase complex subunit 3 , KAT9
Background: ELP3 is the catalytic subunit of the histone acetyltransferase elongator complex, which contributes to transcript elongation and also regulates the maturation of projection neurons (Creppe et al., 2009 [PubMed 19185337]).[supplied by OMIM]
-
Molekulargewicht
- 62 kDa
-
Gen-ID
- 55140
-
UniProt
- Q9H9T3
Target
-